135 related articles for article (PubMed ID: 7658304)
1. Fungal cultures on cyanoacrylate skin surface strippings as a dose-finding method for topical antifungals. A placebo-controlled study with 0.25% and 0.50% itraconazole cream.
Arrese JE; Schrooten P; de Doncker P; de Smett H; Cauwenbergh G; Piérard-Franchimont C; Piérard GE
J Med Vet Mycol; 1995; 33(2):127-30. PubMed ID: 7658304
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study.
Piérard GE; Arrese JE; De Doncker P
J Am Acad Dermatol; 1995 Mar; 32(3):429-35. PubMed ID: 7868711
[TBL] [Abstract][Full Text] [Related]
3. Activity of the triazole antifungal r126638 as assessed by corneofungimetry.
Piérard-Franchimont C; Ausma J; Wouters L; Vroome V; Vandeplassche L; Borgers M; Cauwenbergh G; Piérard GE
Skin Pharmacol Physiol; 2006; 19(1):50-6. PubMed ID: 16247249
[TBL] [Abstract][Full Text] [Related]
4. Itraconazole corneofungimetry bioassay on Malassezia species.
Piérard GE; Arrese JE; Piérard-Franchimont C
Mycoses; 2004 Oct; 47(9-10):418-21. PubMed ID: 15504126
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation the antimycotic activity of itraconazole in human stratum corneum with vitro fungi cultivation].
Xu W; Zhao JY; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):530-3. PubMed ID: 15949332
[TBL] [Abstract][Full Text] [Related]
6. [A new bioassay model of antibiotic susceptibility by corneofungimetry].
Zhao JY; Xu W; Wang L; Jiang DL; Li YZ
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(5):332-5. PubMed ID: 16677528
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the activity and lingering effect of topical antifungals.
Piérard GE; Piérard-Franchimont C; Estrada JA
Skin Pharmacol; 1993; 6(3):208-14. PubMed ID: 8274291
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical response to itraconazole treatment in a patient with onychomycosis caused by Microsporum gypseum.
Pierard-Franchimont G; De Doncker P; Van de Velde V; Jacqmin P; Arrese JE; Pierard GE
Ann Soc Belg Med Trop; 1995 Sep; 75(3):211-7. PubMed ID: 8849298
[TBL] [Abstract][Full Text] [Related]
9. Oral itraconazole versus topical bifonazole treatment in experimental dermatophytosis.
Borgers M; Xhonneux B; Van Cutsem J
Mycoses; 1993; 36(3-4):105-15. PubMed ID: 8396203
[TBL] [Abstract][Full Text] [Related]
10. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
[TBL] [Abstract][Full Text] [Related]
11. Reduction in the growth of non-dermatophyte moulds by itraconazole: evaluation by corneofungimetry assay.
Arrese JE; De Doncker P; Odds FC; Piérard GE
Mycoses; 1998 Dec; 41(11-12):461-5. PubMed ID: 9919887
[TBL] [Abstract][Full Text] [Related]
12. The use of itraconazole to treat cutaneous fungal infections in children.
Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
[TBL] [Abstract][Full Text] [Related]
13. The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes.
Korting HC; Schöllmann C
J Dtsch Dermatol Ges; 2009 Jan; 7(1):11-9, 11-20. PubMed ID: 18479501
[TBL] [Abstract][Full Text] [Related]
14. Euclidean and fractal computer-assisted corneofungimetry: a comparison of 2% ketoconazole and 1% terbinafine topical formulations.
Arrese JE; Fogouang L; Piérard-Franchimont C; Piérard GE
Dermatology; 2002; 204(3):222-7. PubMed ID: 12037451
[TBL] [Abstract][Full Text] [Related]
15. Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature.
Nikkels AF; Nikkels-Tassoudji N; Piérard GE
Am J Clin Dermatol; 2006; 7(5):327-31. PubMed ID: 17007544
[TBL] [Abstract][Full Text] [Related]
16. Effect of Lamisil and azole antifungals in experimental nail infection.
Richardson MD
Dermatology; 1997; 194 Suppl 1():27-31. PubMed ID: 9154398
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
[TBL] [Abstract][Full Text] [Related]
19. Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo.
Svejgaard El; Larsen PØ; Deleuran M; Ternowitz T; Roed-Petersen J; Nilsson J
J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):445-9. PubMed ID: 15196159
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
